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The number of metastases is an important prognostic fac-tor. Because of the discrepancy between what is seen
radiographically and what is found at surgery, it is important
to distinguish between the number of nodules seen preoper-
atively and the number of metastases found pathologically in
the resected specimens. Unfortunately, most of the reported
data define the number of resected metastases and not the
number of imaged nodules.
There is ample evidence that the fewer the number of
metastases present, the better the postresection survival.1–7
Many studies have reported that the 5-year survival of pa-
tients with only one metastasis identified at surgery was
markedly better than that of patients who were found to have
multiple metastases (average, 47% versus 17%; range, 35–
53% versus 8–26%).3–7 The International Registry study8
found that the 5-year survival of patients with one metastasis
was better than that of patients with two to three metastases,
who, in turn, survive longer than the patients with four or
more metastases (5-year survival 43% versus 34% versus
27%, respectively). However, at 15 years, there was no
difference among patients with more than one metastasis, and
only those with a solitary metastasis exhibited better survival.
When outcomes in the Registry data were corrected for the
influence of other prognostic factors, independent prognostic
significance was associated primarily with the presence of
only one pulmonary metastasis, whereas the number of me-
tastases more than one had little importance.8
There does not seem to be a threshold number of
metastases found intraoperatively above which resection be-
comes futile. In the past, some surgeons limited their resec-
tions to less than or equal to four lesions, because it was felt
that a number greater than this made the patient’s disease
unresectable.9 One study suggested that the patients with
more than six metastases found intraoperatively were likely
to be unresectable,10 but it reported that the 5-year survival of
such patients was 20% (compared with nearly 40% in patients
with six or fewer metastases). The International Registry
found a 5-year survival of 26% in patients with four or more
lesions who underwent complete resection.8 Another study
involving 44 patients (with various cancer types) who under-
went resection of eight or more metastases found no signif-
icant survival difference compared with 412 patients with
fewer than eight nodules (5-year survivals of 28 and 34%,
respectively).11 The survival rates in these studies in patients
in whom multiple metastases were resected are high enough
to justify the procedure. Thus, there seems to be no reason to
abort a metastasectomy operation no matter how many me-
tastases are found intraoperatively as long as a complete
resection can be accomplished and the patient can tolerate the
procedure. Anecdotally, up to 117 metastases have been
resected (in multiple operations) in a patient with soft tissue
sarcoma with no further recurrences 6 1⁄2 years after the last
resection.11
The important clinical question is whether patients in
whom resection is not warranted can be identified preopera-
tively. Patients with a single pulmonary nodule (identified
preoperatively) have been shown to have better survival than
patients with multiple nodules seen preoperatively.5,12 The
studies involving the patients with sarcomas have found an
average 5-year survival of 34% (range, 15–47%) among
patients with less than or equal to 4 (or sometimes less than
or equal to three or five) nodules, whereas the average of
5-year survival was 2% (range, 0–8%) among patients with
more than four preoperatively identified nodules.13–16 An-
other study involving 417 patients with renal metastasis
found that the chance of an incomplete resection was approx-
imately 80% with more than or equal to six versus 20% with
less than or equal to 3 preoperatively identified nodules.17
However, many studies have reported a 5-year survival of
approximately 20 to 25% in patients with more than four
nodules as counted postoperatively.8,18,19 This discrepancy in
results makes it unclear whether a threshold number of
lesions can be defined above which metastasectomy seems
futile, provided a complete resection is anticipated.
REFERENCES
1. Putnam JB Jr, Roth JA. Prognostic indicators in patients with pulmonary
metastases. Semin Surg Oncol 1990;6:291–296.
2. Friedel G, Hu¨rtgen M, Penzenstadler M, et al. Resection of pulmonary
metastases from renal cell carcinoma. Anticancer Res 1999;19:1593–
1596.
3. Harpole DH Jr, Johnson CM, Wolfe WG, et al. Analysis of 945 cases of
pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992;103:
743–750.
Section of Thoracic Surgery, Yale University School of Medicine, Yale
Cancer Center Thoracic Oncology Program, New Haven, CT.
Disclosure: The author declares no conflicts of interest.
Address for correspondence: Frank Detterbeck, MD, 330 Cedar Street,
Yale University, New Haven, CT 06520. E-mail: frank.detterbeck@
yale.com
Copyright © 2010 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/10/0506-0164
Journal of Thoracic Oncology • Volume 5, Number 6, Supplement 2, June 2010S164
4. Mansel JK, Zinsmeister AR, Pairolero PC, et al. Pulmonary resection of
metastatic colorectal adenocarcinoma: a ten year experience. Chest
1986;89:109–112.
5. Girard P, Ducreux M, Baldeyrou P, et al. Surgery for lung metastases
from colorectal cancer: analysis of prognostic factors. J Clin Oncol
1996;14:2047–2053.
6. Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for
metastatic colorectal cancer: experiences with 159 patients. J Thorac
Cardiovasc Surg 1996;112:867–874.
7. Goya T, Miyazawa N, Kondo H, et al. Surgical resection of pulmonary
metastases from colorectal cancer: ten year follow-up. Cancer 1989;64:
1418–1421.
8. Pastorino U; for The International Registry of Lung Metastases. Long-
term results of lung metastasectomy: prognostic analyses based on 5206
cases. J Thorac Cardiovasc Surg 1997;113:37–49.
9. Morton DL, Joseph WL, Ketcham AS, et al. Surgical resection and
adjunctive immunotherapy for selected patients with multiple pulmonary
metastases. Ann Surg 1973;178:360–366.
10. Vogt-Moykopf I, Bulzebruck H, Merkle NM. Results of surgical treat-
ment of pulmonary metastases. Eur J Cardiothorac Surg 1988;2:224–
232.
11. Girard P, Baldeyrou P, Le Chevalier T, et al. Surgical resection of
pulmonary metastases: up to what number? Am J Respir Crit Care Med
1994;149:469–476.
12. Takita H, Edgerton F, Karakousis C, et al. Surgical management of
metastases to the lung. Surg Gynecol Obstet 1981;152:191–194.
13. Roth JA, Putnam JB Jr, Wesley MN, et al. Differing determinants of
prognosis following resection of pulmonary metastases from osteogenic
and soft tissue sarcoma patients. Cancer 1985;55:1361–1366.
14. Jablons D, Steinberg SM, Roth J, et al. Metastasectomy for soft tissue
sarcoma: further evidence for efficacy and prognostic indicators. J Tho-
rac Cardiovasc Surg 1989;97:695–705.
15. Casson A, Putnam J, Natarajan G, et al. Five-year survival after pulmo-
nary metastasectomy for adult soft tissue sarcoma. Cancer 1992;69:662–
668.
16. Meyer WH, Schell MJ, Jumar PM, et al. Thoracotomy for pulmonary
metastatic osteosarcoma: an analysis of prognostic indicators of survival.
Cancer 1987;59:374–379.
17. Murthy SC, Kim K, Rice TW, et al. Can we predict long-term survival
after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac
Surg 2005;79:996–1003.
18. Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasec-
tomy from breast cancer: prognostic criteria on the basis of 467 cases of
the international registry of lung metastases. Eur J Cardiothorac Surg
2002;22:335–344.
19. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of
pulmonary metastases from colorectal cancer: a systematic review of
published series. Ann Thorac Surg 2007;84:324–338.
Journal of Thoracic Oncology • Volume 5, Number 6, Supplement 2, June 2010Number of Metastases and Its Influence on Outcome
Copyright © 2010 by the International Association for the Study of Lung Cancer S165
